What is Conceive?
Founded in 2021 and headquartered in New York City, Conceive operates as a digital fertility and health platform provider. The company aims to leverage technology to support individuals through their fertility journeys, offering a comprehensive digital solution in a rapidly evolving health-tech landscape. The recent enterprise-level funding suggests a strategic push towards scaling operations and expanding its service offerings.
How much funding has Conceive raised?
Conceive has raised a total of $3.7M across 1 funding round:
Angel/Seed
$3.7M
Angel/Seed (2022): $3.7M with participation from Great Oaks, Founder Collective, and Kindred Ventures
Key Investors in Conceive
Great Oaks
Great Oaks, an educational institution, participated in this funding round, indicating a potential interest in the intersection of education and health technology.
Founder Collective
Founder Collective, a venture capital fund focused on seed and pre-seed investments, has backed Conceive, signaling their belief in early-stage innovative startups with strong founder alignment.
Kindred Ventures
Kindred Ventures is an investor in Conceive's funding round, contributing to the company's growth capital.
What's next for Conceive?
The substantial enterprise-level funding positions Conceive for significant growth and market expansion. This capital infusion is likely to be directed towards enhancing its platform's capabilities, broadening its user base, and potentially exploring strategic partnerships within the healthcare ecosystem. The focus on a major strategic investment indicates a clear roadmap for leveraging this financing to solidify its market presence and drive innovation in digital health.
See full Conceive company page
